La Filière de Santé Maladies Rares TÊTECOU
Myriam de Chalendar, Nicolas Leboulanger(Hôpital Necker-Enfants Malades), Lisa Friedlander(Hôpital Necker-Enfants Malades)
Cited by 1
Related Papers
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience
|International Journal of Pediatric Otorhinolaryngology|2010|110
Laryngo-tracheo-oesophageal clefts
|Orphanet Journal of Rare Diseases|2011|105
Use of P-values and the terms “significant”, “non-significant” and “suggestive” in Abstracts in the European Annals of Otorhinolaryngology, Head & Neck Diseases
|European Annals of Otorhinolaryngology Head and Neck Diseases|2019|105